Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Twist Bioscience Corp Director's Dealing 2021

Nov 3, 2021

31873_dirs_2021-11-03_188dd9a7-9cac-4c70-a92f-9151b1a0ee17.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2021-11-01

Reporting Person: CHESS ROBERT (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-11-01 Common Stock S 4000 $120.1534 Disposed 51014 Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on February 12, 2021.

F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $120.00 to $120.89 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.